Studies of the development of congenital anomalies in embryos of riboflavin-deficient, galactoflavin fed rats. I. Growth and embryologic pathology.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000135:Acid Phosphatase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002490:Central Nervous System / Q000002:abnormalities; D004032:Diet; D004622:Embryo, Mammalian / Q000473:pathology; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D005415:Flavins; D005865:Gestational Age; D006651:Histocytochemistry; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D017880:Limb Deformities, Congenital; D008264:Macrophages / Q000502:physiology; D008648:Mesoderm / Q000002:abnormalities; D008938:Mitosis / Q000187:drug effects; D009336:Necrosis; D010587:Phagocytosis; D011247:Pregnancy; D011248:Pregnancy Complications; D051381:Rats; D012256:Riboflavin / Q000037:antagonists & inhibitors*; D012257:Riboflavin Deficiency; D013194:Staining and Labeling; D013385:Succinate Dehydrogenase / Q000378:metabolism
D005415:Flavins; D007770:L-Lactate Dehydrogenase; D013385:Succinate Dehydrogenase; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D012256:Riboflavin